TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $1.14M2022: $1.03M2023: $81.0K2025: $90.0K$90.0K
2021Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$90.0K—
2023$81.0K-92.1%
2022$1.03M-10.0%
2021$1.14M—